Ryan Adist

About the Author Ryan Adist


H.C. Wainwright Keeps Their Buy Rating on Harpoon Therapeutics (HARP)

In a report released today, Swayampakula Ramakanth from H.C.

Similarweb (SMWB) Initiated with a Buy at Oppenheimer

Similarweb (SMWB) received a Buy rating and a $27.00 price target from Oppenheimer analyst Jason Helfstein today.

Raymond James Believes Targa Resources (TRGP) Still Has Room to Grow

Raymond James analyst James Weston maintained a Buy rating on Targa Resources (TRGP) yesterday. The company’s shares closed last Thursday at $41.

Rosenblatt Securities Thinks PDF Solutions’ Stock is Going to Recover

In a report released today, John McPeake from Rosenblatt Securities reiterated a Buy rating on PDF Solutions (PDFS), with a price target of …

BTIG Initiates a Buy Rating on Penumbra (PEN)

BTIG analyst Ryan Zimmerman initiated coverage with a Buy rating on Penumbra (PEN) today and set a price target of $291.00.

CIBC Sticks to Its Sell Rating for L Brands (LB)

CIBC analyst CIBC World Markets maintained a Sell rating on L Brands (LB) yesterday and set a price target of $43.00.

Analysts Offer Insights on Technology Companies: DocuSign (DOCU) and CrowdStrike Holdings (CRWD)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on DocuSign (DOCU) and CrowdStrike Holdings …

Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX), SI-Bone (SIBN) and Metacrine (MTCR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on SCYNEXIS (SCYX), SI-Bone (SIBN) and …

Oppenheimer Assigns a Buy Rating on Aterian (ATER)

Oppenheimer analyst Brian Nagel assigned a Buy rating to Aterian (ATER) today and set a price target of $50.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts